Health
Oxford-AstraZeneca COVID-19 Vaccine To Be Tested On Children For First Time – HuffPost
The new mid-stage trial will determine whether the coronavirus shot is effective on people between the ages of six and 17.
(Reuters) – The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.
Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca…
-
Noosa News18 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News21 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
General16 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News17 hours agoPolice appeal for information after two men found dead